Pharma companies turn to AI to speed up drug development, but hit hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Psychology Today14h
AI Finds Anti-Cancer Drug Candidates With Quantum Computing
AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...
Eli Lilly Seeks To Expand Into Cancer Radiopharma And Fatty Liver, With Two Global Deals
Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for MASH and cardiometabolic diseases.